Nisa Investment Advisors LLC cut its position in Doximity, Inc. (NASDAQ:DOCS – Free Report) by 18.1% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 9,070 shares of the company’s stock after selling 2,000 shares during the quarter. Nisa Investment Advisors LLC’s holdings in Doximity were worth $484,000 at the end of the most recent reporting period.
A number of other institutional investors and hedge funds have also recently bought and sold shares of the company. FMR LLC grew its position in shares of Doximity by 30.5% in the third quarter. FMR LLC now owns 6,837,733 shares of the company’s stock valued at $297,920,000 after purchasing an additional 1,598,602 shares during the last quarter. Clearbridge Investments LLC grew its holdings in Doximity by 7.1% in the 2nd quarter. Clearbridge Investments LLC now owns 5,853,035 shares of the company’s stock valued at $163,709,000 after buying an additional 387,200 shares during the last quarter. State Street Corp increased its position in Doximity by 2.5% in the 3rd quarter. State Street Corp now owns 3,693,982 shares of the company’s stock worth $160,947,000 after buying an additional 88,922 shares during the period. Geode Capital Management LLC lifted its holdings in shares of Doximity by 19.8% during the third quarter. Geode Capital Management LLC now owns 2,856,984 shares of the company’s stock worth $124,503,000 after buying an additional 472,565 shares during the last quarter. Finally, Dimensional Fund Advisors LP boosted its position in shares of Doximity by 28.5% in the second quarter. Dimensional Fund Advisors LP now owns 1,267,067 shares of the company’s stock valued at $35,439,000 after acquiring an additional 281,239 shares during the period. Institutional investors and hedge funds own 87.19% of the company’s stock.
Doximity Stock Up 3.3 %
NASDAQ:DOCS opened at $57.17 on Wednesday. The firm has a market cap of $10.67 billion, a PE ratio of 65.71, a price-to-earnings-growth ratio of 4.43 and a beta of 1.38. The company’s 50-day moving average price is $53.98 and its two-hundred day moving average price is $44.06. Doximity, Inc. has a 12 month low of $22.96 and a 12 month high of $61.75.
Analyst Upgrades and Downgrades
Several equities analysts recently commented on DOCS shares. Morgan Stanley upgraded shares of Doximity from an “underweight” rating to an “equal weight” rating and upped their target price for the company from $33.00 to $53.00 in a research note on Thursday, November 14th. Truist Financial upped their price objective on shares of Doximity from $35.00 to $49.00 and gave the company a “hold” rating in a research report on Thursday, November 14th. Bank of America lifted their target price on Doximity from $54.00 to $57.00 and gave the stock a “neutral” rating in a research report on Monday, January 6th. Wells Fargo & Company upped their price target on Doximity from $41.00 to $43.00 and gave the company an “equal weight” rating in a report on Monday, January 13th. Finally, JPMorgan Chase & Co. lifted their price objective on Doximity from $30.00 to $48.00 and gave the stock a “neutral” rating in a report on Thursday, November 21st. Thirteen analysts have rated the stock with a hold rating, six have issued a buy rating and one has issued a strong buy rating to the company. According to MarketBeat.com, the stock has an average rating of “Hold” and an average target price of $53.12.
Check Out Our Latest Report on Doximity
Doximity Company Profile
Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.
Featured Stories
- Five stocks we like better than Doximity
- How to Most Effectively Use the MarketBeat Earnings Screener
- Survey Reveals: Top 150 Best Coffee Shops for Remote Workers and Business Deals [2025]
- Insider Selling Explained: Can it Inform Your Investing Choices?
- What Does the Future Hold for Eli Lilly?
- 2 Fintech Stocks to Buy Now and 1 to Avoid
- Oracle Stock Drops Nearly 14% – Is Now the Time to Buy?
Receive News & Ratings for Doximity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Doximity and related companies with MarketBeat.com's FREE daily email newsletter.